Inventor · disambiguated record
Robert F. Kelley
Also filed as: KELLEY JR ROBERT FRANKLIN · KELLEY ROBERT · KELLEY ROBERT F · KELLEY ROBERT FRANKLIN
52 granted patents·32 pending applications·529 citations·filing 1975–2024
98Inventor score
Top patents by PatentIndex Score
84 records- 0195US8372403B2Humanized anti-factor D antibodies and uses thereofGENENTECH INC·Filed 2012·Granted Feb 12, 2013·17 cites·31 claims
- 0295US8067002B2Humanized anti-factor D antibodiesAN LING-LING·Filed 2007·Granted Nov 29, 2011·29 cites·28 claims
- 0394US10865251B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2018·Granted Dec 15, 2020·6 cites·20 claims
- 0494US8133488B2Methods and compositions for targeting polyubiquitinKELLEY ROBERT F·Filed 2009·Granted Mar 13, 2012·20 cites·6 claims
- 0594US5874407AFactor VIIA inhibitorsGENENTECH INC·Filed 1997·Granted Feb 23, 1999·113 cites·4 claims
- 0693US8193329B2Nucleic acids encoding anti-factor D antibodiesAN LING-LING·Filed 2011·Granted Jun 5, 2012·15 cites·44 claims
- 0792US8273352B2Humanized anti-factor D antibodies and uses thereofHUANG ARTHUR·Filed 2009·Granted Sep 25, 2012·30 cites·35 claims
- 0892US8187604B2Methods of treating with anti-factor D antibodiesAN LING-LING·Filed 2011·Granted May 29, 2012·12 cites·39 claims
- 0992US7763245B2Methods and compositions for targeting polyubiquitinGENENTECH INC·Filed 2006·Granted Jul 27, 2010·23 cites·60 claims
- 1091US10421822B2Anti-HtrA1 antibodies and methods of use thereofGENENTECH INC·Filed 2018·Granted Sep 24, 2019·4 cites·52 claims
- 1191US10174124B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2014·Granted Jan 8, 2019·11 cites·14 claims
- 1291US8753826B2Methods of detecting factor D with anti-factor D antibodiesGENENTECH INC·Filed 2013·Granted Jun 17, 2014·8 cites·32 claims
- 1391US2025243265A1Anti-Polyubiquitin AntibodiesGENENTECH INC·Filed 2024·Application pending·0 cites
- 1490US8105603B2Polypeptides that bind APRILKELLEY ROBERT F·Filed 2009·Granted Jan 31, 2012·29 cites·26 claims
- 1589US10035849B2Methods and compositions for targeting polyubiquitinGENENTECH INC·Filed 2016·Granted Jul 31, 2018·5 cites·23 claims
- 1689US9365642B2Methods and compositions for targeting polyubiquitinGENENTECH INC·Filed 2015·Granted Jun 14, 2016·5 cites·22 claims
- 1788US10738106B2Nucleic acids encoding anti-polyubiquitin antibodiesGENENTECH INC·Filed 2016·Granted Aug 11, 2020·3 cites·20 claims
- 1888US8992919B2Anti-polyubiquitin antibodies and methods of useDIXIT VISHVA·Filed 2011·Granted Mar 31, 2015·13 cites·20 claims
- 1987US10640572B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2017·Granted May 5, 2020·2 cites·18 claims
- 2087US10501545B2Anti-CLL-1 antibodies and methods of useGENENTECH INC·Filed 2016·Granted Dec 10, 2019·6 cites·31 claims
- 2187US2024067709A1Methods and Compositions for Targeting PolyubiquitinGENENTECH INC·Filed 2023·Application pending·0 cites
- 2286US11597761B2Methods of detecting polyubiquitin using anti-polyubiquitin antibodiesGENENTECH INC·Filed 2020·Granted Mar 7, 2023·1 cites·20 claims
- 2386US8603475B2Methods and compositions for targeting polyubiquitinGORDON NATHANIEL C·Filed 2010·Granted Dec 10, 2013·15 cites·28 claims
- 2486US5736364AFactor viia inhibitorsGENENTECH INC·Filed 1995·Granted Apr 7, 1998·47 cites·21 claims
- 2586US2024067752A1ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOFGENENTECH INC·Filed 2023·Application pending·0 cites
- 2685US11732054B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2020·Granted Aug 22, 2023·1 cites·56 claims
- 2785US11530275B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2020·Granted Dec 20, 2022·1 cites·20 claims
- 2885US10421821B2Anti-HtrA1 antibodies and methods of use thereofGENENTECH INC·Filed 2016·Granted Sep 24, 2019·2 cites·44 claims
- 2985US10407510B2Anti-factor D antibodies and conjugatesGENENTECH INC·Filed 2016·Granted Sep 10, 2019·10 cites·126 claims
- 3085US10100105B2Anti-polyubiquitin antibodies and methods of useGENENTECH INC·Filed 2016·Granted Oct 16, 2018·3 cites·24 claims
- 3185US9081015B2Methods and compositions for targeting polyubiquitinKELLEY ROBERT F·Filed 2012·Granted Jul 14, 2015·5 cites·22 claims
- 3285US8614306B2Polynucleotides encoding humanized anti-factor D antibodiesHUANG ARTHUR·Filed 2012·Granted Dec 24, 2013·7 cites·27 claims
- 3384US12466896B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2022·Granted Nov 11, 2025·0 cites·31 claims
- 3484US12286470B2Methods of determining the function of polyubiquitin using anti-polyubiquitin antibodiesGENENTECH INC·Filed 2023·Granted Apr 29, 2025·0 cites·17 claims
- 3584US9321844B2Anti-polyubiquitin antibodiesKELLEY ROBERT F·Filed 2012·Granted Apr 26, 2016·5 cites·17 claims
- 3683US11512143B2Anti-HtrA1 antibodies and methods of use thereofGENENTECH INC·Filed 2019·Granted Nov 29, 2022·1 cites·21 claims
- 3783US11186650B2Anti-CD3 antibodies and methods of useGENENTECH INC·Filed 2018·Granted Nov 30, 2021·1 cites·79 claims
- 3882US2023383008A1ANTI-HtrA1 ANTIBODIES AND METHODS OF USE THEREOFGENENTECH INC·Filed 2022·Application pending·0 cites
- 3981US9556262B2Anti-polyubiquitin antibodies and methods of useGENENTECH INC·Filed 2015·Granted Jan 31, 2017·2 cites·13 claims
- 4081US9487578B2Methods and compositions for targeting polyubiquitinGENENTECH INC·Filed 2013·Granted Nov 8, 2016·4 cites·21 claims
- 4179US12037385B2Anti-polyubiquitin antibodies and methods of useGENENTECH INC·Filed 2021·Granted Jul 16, 2024·0 cites·14 claims
- 4277US9676868B2Humanized anti-factor D antibodies and uses thereofGENENTECH INC·Filed 2013·Granted Jun 13, 2017·2 cites·35 claims
- 4377US6740739B1Substitutional variants of APO-2 ligandGENENTECH INC·Filed 1999·Granted May 25, 2004·37 cites·4 claims
- 4477US3979147ATransparent cover with connecting devices for motorcycles and ridersKELLEY ROBERT F·Filed 1975·Granted Sep 7, 1976·26 cites·2 claims
- 4576US11753464B2Methods and compositions for targeting polyubiquitinGENENTECH INC·Filed 2020·Granted Sep 12, 2023·0 cites·19 claims
- 4672US10961313B2Anti-factor D antibody variant conjugates and uses thereofGENENTECH INC·Filed 2019·Granted Mar 30, 2021·0 cites·41 claims
- 4771US2023279090A1Non-covalent protein-hyaluronan conjugates for long-acting ocular deliveryGENENTECH INC·Filed 2023·Application pending·0 cites
- 4871US2023256107A1Hyaluronic acid binding derivatives of versican (vg1) for long acting delivery of therapeuticsGENENTECH INC·Filed 2023·Application pending·0 cites
- 4970US11066463B2Anti-polyubiquitin antibodies and methods of useGENENTECH INC·Filed 2018·Granted Jul 20, 2021·0 cites·15 claims
- 5070US10808028B2Methods and compositions for targeting polyubiquitinGENENTECH INC·Filed 2018·Granted Oct 20, 2020·0 cites·18 claims
Showing the top 50 of 84 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Robert F. Kelley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →